Page last updated: 2024-09-05
sb 216763 and nephrin
sb 216763 has been researched along with nephrin in 1 studies
Compound Research Comparison
| Studies (sb 216763) | Trials (sb 216763) | Recent Studies (post-2010) (sb 216763) | Studies (nephrin) | Trials (nephrin) | Recent Studies (post-2010) (nephrin) |
|---|---|---|---|---|---|
| 342 | 0 | 225 | 1,130 | 9 | 621 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| George, B; Huber, TB; Pavenstädt, H; Saleem, MA; Vollenbröker, B; Weide, T | 1 |
Other Studies
1 other study(ies) available for sb 216763 and nephrin
| Article | Year |
|---|---|
GSK3β inactivation in podocytes results in decreased phosphorylation of p70S6K accompanied by cytoskeletal rearrangements and inhibited motility.
Topics: Adaptor Proteins, Signal Transducing; Cell Line; Cell Movement; Cytoskeletal Proteins; Cytoskeleton; Humans; Immunosuppressive Agents; Indoles; Lithium Chloride; Maleimides; Membrane Proteins; Nuclear Proteins; Oncogene Proteins; Phosphorylation; Podocytes; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; WT1 Proteins | 2011 |